Holen Sie sich die Stockscreener-App
1.11
0.89%
-0.01
Schlusskurs vom Vortag:
$1.12
Offen:
$1.12
24-Stunden-Volumen:
248.11K
Relative Volume:
0.49
Marktkapitalisierung:
$50.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.56M
KGV:
-0.9487
EPS:
-1.17
Netto-Cashflow:
$-35.28M
1W Leistung:
+1.83%
1M Leistung:
-12.60%
6M Leistung:
-23.97%
1J Leistung:
-63.61%
1-Tages-Spanne:
$1.08
$1.17
1-Wochen-Bereich:
$1.06
$1.17
52-Wochen-Spanne:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Firmenname
Pds Biotechnology Corporation
Sektor
Branche
Telefon
800-208-3343
Adresse
303A COLLEGE ROAD EAST, PRINCETON
Vergleichen Sie PDSB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.11 | 50.74M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-01 | Eingeleitet | B. Riley Securities | Buy |
| 2021-06-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-10-24 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Pds Biotechnology Corporation Aktie (PDSB) Neueste Nachrichten
Evaluating PDS Biotechnology Corporation with trendline analysisAI Pattern Recognition and Trade Prediction - Newser
Using Python tools to backtest PDS Biotechnology Corporation strategiesBuy Alert Based on RSI and Volume - Newser
Detecting price anomalies in PDS Biotechnology Corporation with AIScalable Strategy with Chart Confirmation - Newser
What institutional flow reveals about PDS Biotechnology CorporationFree Breakout Confirmation With Entry Tracker - Newser
Statistical indicators supporting PDS Biotechnology Corporation’s strengthDaily Stock Forecast Powered by AI Tools - Newser
Why PDS Biotechnology Corporation stock attracts strong analyst attentionMomentum-Based Prediction for Quick Returns - Newser
How to build a dashboard for PDS Biotechnology Corporation stockFree Trade Insight With Community Collaboration - Newser
What Fibonacci levels say about PDS Biotechnology Corporation reboundFree Breakout Confirmation With Entry Tracker - Newser
Real time social sentiment graph for PDS Biotechnology CorporationEntry Zone Watchlist With Momentum Focus - Newser
Pds Biotechnology Corporation shares rise 1.80% after-hours following Singapore Exchange's strong financial performance. - AInvest
What earnings revisions data tells us about PDS Biotechnology CorporationSmart Risk Strategy with Entry Optimization - Newser
What the charts say about PDS Biotechnology Corporation todayOversold Opportunity Scanner with RSI Data - Newser
Smart tools for monitoring PDS Biotechnology Corporation’s price actionFree Investment Strategy With Low Risk - Newser
PDS Biotech Announces Q2 2025 Earnings Call and Webcast - AInvest
Can trapped investors hope for a rebound in PDS Biotechnology CorporationEntry Confirmation Based on Volatility Analysis - Newser
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results - GlobeNewswire
Is PDS Biotechnology Corporation reversing from oversold territoryFree Daily Chart Pattern Stock Forecast - Newser
When is PDS Biotechnology Corporation stock expected to show significant growthPhenomenal trading returns - Jammu Links News
Should I hold or sell PDS Biotechnology Corporation stock in 2025Turn market volatility into profit opportunities - Jammu Links News
Risk adjusted return profile for PDS Biotechnology Corporation analyzedFree Expert Verified Stock Trade Ideas - Newser
Is PDS Biotechnology Corporation a growth stock or a value stockUnstoppable trading performance - Jammu Links News
Published on: 2025-08-04 02:03:30 - Jammu Links News
What is the risk reward ratio of investing in PDS Biotechnology Corporation stockOutstanding capital returns - Jammu Links News
How does PDS Biotechnology Corporation generate profit in a changing economyAchieve consistent profits with smart trading - Jammu Links News
What are the latest earnings results for PDS Biotechnology CorporationCapitalize on market trends with expert guidance - Jammu Links News
What drives PDS Biotechnology Corporation stock priceGet daily updates on the hottest stocks - Jammu Links News
PDS Biotechnology Corporation Stock Analysis and ForecastExpert guidance for superior capital growth - Jammu Links News
What analysts say about PDS Biotechnology Corporation stockInvest smarter with comprehensive market analysis - Jammu Links News
What catalysts could drive PDS Biotechnology Corporation stock higher in 2025Extraordinary profit generation - Jammu Links News
What are PDS Biotechnology Corporation company’s key revenue driversAccelerated capital growth - Jammu Links News
What is the dividend policy of PDS Biotechnology Corporation stockGet ahead with breakthrough trading ideas - Jammu Links News
Published on: 2025-08-02 03:00:07 - Newser
New Product Launches: Will They Boost PDS Biotechnology Corporation Stock in 2025Market Downturn Defense Strategy Analysis - Newser
Long term hold vs stop loss in PDS Biotechnology CorporationStrategy Builder for Growth Focused Traders - Newser
What does recent volatility data suggest for PDS Biotechnology CorporationFree Intraday Trend Analysis for Fast Gains - Newser
Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):